Apollo continues to invest in genomics technology and research for better patient careApollo, the world’s largest vertically integrated healthcare provider, has announced the expansion of the Apollo Genomics Institute with the launch of Gujarat’s first facility in Ahmedabad.
Doubling down on its investments in genomics, Apollo Genomics Institute was earlier launched in Mumbai, Delhi, Chennai, Hyderabad, and Kolkata.
The Apollo Genomics Institute aims to transform medical practice by bringing genomic services within the reach of every clinician & patient.
The institute in Ahmedabad will host a range of genomic services including genetic evaluation, clinical diagnostics, obstetric genetics, cancer genomics, prenatal genetic screening capabilities and more, empowering patients with information to manage and prevent genetic disorders.
This also enables personalisation in medicine by leveraging genetic insights is immensely impacting decisions made regarding the prevention, diagnosis, and treatment of diseases."
Apollo continues to invest in genomics technology and research for better patient care
Apollo, the world’s largest vertically integrated healthcare provider, has announced the expansion of the Apollo Genomics Institute with the launch of Gujarat’s first facility in Ahmedabad. Doubling down on its investments in genomics, Apollo Genomics Institute was earlier launched in Mumbai, Delhi, Chennai, Hyderabad, and Kolkata.
The Apollo Genomics Institute aims to transform medical practice by bringing genomic services within the reach of every clinician & patient.
The institute in Ahmedabad will host a range of genomic services including genetic evaluation, clinical diagnostics, obstetric genetics, cancer genomics, prenatal genetic screening capabilities and more, empowering patients with information to manage and prevent genetic disorders.
Dr Madhu Sasidhar, President & CEO Hospital Division, Apollo Hospitals Group said, “Constantly increasing availability of real-world data sources coupled with patient-centric analytics offer deeper insights into how they are diagnosed, treated and beyond. Genomics is one such area. On the back of increasing NCDs, the greater availability of patient-level data helps practitioners better understand the patient’s journey. This also enables personalisation in medicine by leveraging genetic insights is immensely impacting decisions made regarding the prevention, diagnosis, and treatment of diseases."
Dr Anupam Sibal, Group Medical Director, Apollo Hospitals said, “Genetics plays a crucial role in understanding various diseases and conditions, and with the establishment of Apollo Genomics Institutes, we are poised to offer comprehensive genetic testing, counselling, and personalized treatment options to our patients."
